Alvotech (ALVO) EBIT Margin (2022 - 2026)

Alvotech (ALVO) posted EBIT Margin of 18.9% for Q1 2026, down 97.61% on a QoQ basis from 790.72% in Q4 2025, and down 5647.0% year-over-year from 0.34% in Q1 2025.

Alvotech (ALVO) EBIT Margin (2022 - 2026) Analysis & Trends

Alvotech's EBIT Margin history runs 5 years deep, the most recent figure standing at 18.9% for Q1 2026.

  • Quarterly EBIT Margin fell 5647.0% year-over-year to 18.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.32% (up 40118.0% YoY) and the FY2025 annual result came in at 28.31%, up 284.0% from the prior year.
  • EBIT Margin was 18.9% for Q1 2026 at Alvotech, down from 790.72% in the prior quarter.
  • Across five years, EBIT Margin topped out at 790.72% in Q4 2025 and bottomed at 15988.05% in Q1 2022.
  • A 5-year average of 1739.58% and a median of 390.06% in 2024 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2023 — EBIT Margin jumped 1538118 bps — and 2025, when it tumbled 132854 bps.
  • Alvotech's EBIT Margin stood at 2514.82% in 2022, then climbed by 25 bps to 1877.67% in 2023, then jumped by 85 bps to 291.02% in 2024, then jumped by 372 bps to 790.72% in 2025, then slumped by 98 bps to 18.9% in 2026.
  • Business Quant data shows ALVO's EBIT Margin at 18.9% in Q1 2026, 790.72% in Q4 2025, and 929.24% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 18.90%

Historic Data

Download Data
DateValue
Mar 31, 2026 18.90%
Dec 31, 2025 790.72%
Sep 30, 2025 -929.24%
Jun 30, 2025 -9.22%
Mar 31, 2025 75.37%
Dec 31, 2024 -291.02%
Sep 30, 2024 399.30%
Jun 30, 2024 -390.06%
Mar 31, 2024 -389.53%
Dec 31, 2023 -1,877.67%
Jun 30, 2023 -608.07%
Mar 31, 2023 -606.87%
Dec 31, 2022 -2,514.82%
Jun 30, 2022 -3,773.51%
Mar 31, 2022 -15,988.05%